Searchable abstracts of presentations at key conferences in endocrinology

ea0009p123 | Endocrine tumours and neoplasia | BES2005

Screening and prevalence of endocrine and radiological pituitary abnormalities in adult-onset Langerhans cell histiocytosis

Jayasena C , Lewis D , Chu A , Meeran K , Devendra D

Adult-onset Langerhans Cell Histiocytosis (LCH) is a rare disease characterised by the abnormal proliferation of Langerhans cells, and has a distinct phenotype to that of childhood-onset LCH. Diabetes Insipidus (DI) is a well-recognised manifestation of LCH, caused by infiltration of the hypothalamo-pituitary axis (HPA). Anterior pituitary dysfunction is an uncommon complication of LCH, which has been shown to be associated with DI. However, this association has previously onl...

ea0003oc47 | Neuroendocrinology | BES2002

A2B adenosine receptors mediate the adenosine-induced increase in cell growth and IL-6 expression in pituitary folliculostellate cells

Rees D , Lewis M , Lewis B , Scanlon M , Ham J

Coordinated interaction between the immune and neuroendocrine systems is of key importance in regulating the host's response to inflammation and anoxic stress. Adenosine, released under such conditions in high concentration, modulates a number of inflammatory processes and can regulate the activity of the hypothalamo-pituitary-adrenal (HPA) axis. Although adenosine receptors (ARs) have been described in the pituitary gland, the distribution of the receptor subtypes (A1, A2A, A...

ea0065p370 | Reproductive Endocrinology and Biology | SFEBES2019

Hyperprolactinaemia resistant to dopamine agonist due to an ectopic source of prolactin arising from a Uterine Tumour Resembling Ovarian Sex Cord Tumours (UTROCST)

Arshad Sobia , Bakhit Mohammed , Bidmead J , Lewis D , Diaz-cano S , Aylwin Simon , Delane Wajman

A 46 year old female presented with 12 months history of secondary amenorrhoea. Prolactin was 4746 mIU/l without macroprolactin complexes, LH & FSH were low, oestradiol was undetectable. She had normal visual fields. No other clinical or biochemical features of pituitary dysfunction. She had no regular medication. Pituitary MRI was normal. She was started on cabergoline 250 mcg twice weekly which was subsequently increased to 500 mcg twice weekly. Repeat serum prolactin 5 ...

ea0007p259 | Clinical case reports | BES2004

Diagnostic difficulty in differentiating between meningioma and pituitary adenoma

Hatfield E , Lewis D , Powell M , Ng K , Kong C , Johnston C

We report two patients (AB 41 years, LS 55 years) presenting with symptoms of hyperprolactinaemia. Prolactin levels were moderately elevated: 1539 (AB), 1186 (LS) (NR 59-619 mU/L). The remainder of the pituitary profile was normal. Neither patient had visual field defects. MRIs (without contrast) reported pituitary macroadenoma with suprasellar extension but no optic chiasm compression. The initial diagnosis was of probable non-functioning adenoma causing stalk compression. Bo...

ea0005oc27 | Brain and Behaviour | BES2003

Adenosine-induced IL-6 expression in pituitary folliculostellate cells is mediated via A2b adenosine receptors coupled to p38 MAPK

Rees D , Lewis B , Lewis M , Francis K , Easter T , Scanlon M , Ham J

Folliculostellate (FS) cells form a three-dimensional network within the anterior pituitary gland and play a key role in regulating the endocrine response to inflammation and anoxic stress. Adenosine, released under such conditions in high concentration, modulates a number of inflammatory processes and can regulate the activity of the hypothalamic-pituitary-adrenal (HPA) axis. The identities of the adenosine receptor (AR) subtypes mediating these responses, however, and the si...